News

The Finep Innovation Award, the most traditional national award dedicated to initiatives that transform strategic sectors of the...

Nintx's most recent scientific article illustrates how our gut microbiome technology can add value to your project ...

Nintx at Food Ingredients South America (FISA) 2025

Nintx’s Founders, Stephani Saverio, Miller Freitas, and Cristiano Guimarães, were present at the BIO International Convention back in June, 2025

The company presented its innovative technologies, pipeline, and vision for the future of therapies based on the human gut microbiome to physicians and nutritionists from Brazil

This was a result of a groundbreaking collaboration between Nintx and the Lactalis Group, the world's largest dairy company Nintx...

By Lilian Caramel - For Valor Econômico 02/26/2025 ...

Startup funding includes a Series A round led by venture capital firms Pitanga, Ecoa Capital and MOV Investimentos, along with a grant...

The startup was recognized among the Top 3 Deep Techs of 2024 together with Decoy and brain4care

This relevant grant from FINEP, in the amount of R$ 13,693,706.67, with a contribution from Nintx in the amount of R$ 1,066,320.00,...

Founded in 2021, the biotech Nintx perfectly illustrates the power of the Brazilian science

Nintx and Centroflora pinpointed an herbaceous plant from the Amazon rainforest to tackle a global multifactorial disease in a...

Board consists of world-leading Brazilian scientists

The startup was also featured on the cover of the magazine’s BIOTECH LATIN AMERICA STARTUPS edition Nintx is honored to have been named...

The seed round, led by deep tech venture capital firm Pitanga, also had the participation of Guilherme Leal (Natura) and Peter Andersen...

Nintx and CIEnP will collaborate on the research of medicinal plants to develop novel therapies for chronic multifactorial inflammatory...

The partnership will build a research laboratory, headed by Prof. Katia Sivieri, to house Nintx’s proprietary xGIbiomics® technology...

Nintx and CNPEM will collaborate on the research of natural products as starting points to develop novel therapies for multifactorial...

The partnership is leveraged by a flagship project that has the potential to treat a multifactorial disease (multi-target therapy) Nintx...

Nintx selects Join Analytics to map medicinal plants with robust scientific evidence Nintx selected Join Analytics Inc., an international...